This inventor holds 2 USPTO granted patents. Top assignee: Sumitomo Pharmaceuticals Company Limited. Active years: 1990-1993.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1990-1993
Title: The Innovations of Yoshio Ito
Introduction
Yoshio Ito is a prominent inventor based in Sagamihara, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that have valuable applications in medicine. With a total of 2 patents to his name, his work continues to impact the industry.
Latest Patents
Yoshio Ito's latest patents include innovative compounds that are crucial in the synthesis of antibiotics. One of his notable patents is for heterocyclic compounds and their production. This patent describes a compound of the formula: ##STR1## wherein R.sub.1, R.sub.2, R.sub.3, and R.sub.4 can be various groups, including hydrogen atoms and alkyl groups. This compound serves as an intermediate in the synthesis of 1.beta.-methylcarbapenem compounds, which are valuable as antibiotics. Another significant patent involves amino acid derivatives and their production. This patent outlines an amino acid derivative of the formula: ##STR1## where R.sup.1 is a protective group for hydroxyl, which is useful as an intermediate for the production of antimicrobial agents.
Career Highlights
Yoshio Ito is currently associated with Sumitomo Pharmaceuticals Company Limited, where he continues to innovate and develop new pharmaceutical compounds. His work has been instrumental in advancing the field of medicinal chemistry.
Collaborations
Yoshio has collaborated with notable colleagues such as Shiro Terashima and Kunikazu Sakai, contributing to various projects that enhance the pharmaceutical landscape.
Conclusion
Yoshio Ito's contributions to the field of pharmaceuticals through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for advancements in antibiotic development and antimicrobial agents.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile